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Summary 
Mucosal tissues  of mice are enriched in T  cells that express the ~//~ T  cell receptor. Since the 
function of these cells remains unclear, we have compared mucosal immune responses in ",//~ T 
cell receptor-deficient (TCRg -/-) mice versus control mice of the same genetic background. 
The frequency of intestinal immunoglobulin (Ig) A plasma cells as well as lgA levels in serum, 
bale, saliva, and fecal samples  were markedly reduced in TCR~ -/- mice. The TCR~ -/- mice 
produced much lower levels of IgA antibodies when immunized orally with a vaccine of teta- 
nus toxoid plus cholera toxin as adjuvant. Conversely, the antigen-specific IgM and IgG anti- 
body responses were comparable to orally immunized control mice. Direct assessment  of the 
cells forming antibodies against the tetanus toxoid and cholera toxin antigens indicated that fig- 
nificantly lower numbers of IgA antibody-producing cells were present in the intestinal lamina 
propria and Peyer's patches of TCR.~ -/- mice compared with the orally immunized control 
mice. The selective reduction of IgA responses to ingested antigens in the absence of ~//~  T 
cells suggests a specialized role for ~//8 T cells in mucosal immunity. 
T 
he mucosal immune system is considered as a separate 
functional  entity  quite  independent  of the  systemic 
immune compartment, since it possesses unique anatomical 
features and is composed of specialized subsets of lymphoid 
cells. For example, the ~//g T  cells are prevalent among the 
intestinal intraepithelial lymphocyte (IEL) population (1-5). 
The underlying lamina propria of the  small  intestine  also 
contains  a  higher frequency of ~//~  T  cells  than  the  sys- 
temic lymphoid tissues (6). Most of the resident ~//~ T  cells 
in intestinal epithelium express cell surface CD8 molecules 
composed of 0tot homodimeric chains (7, 8), and their V~/ 
gene  repertoire differs from  that  of the  systemic "y/~  T 
cells. Thus the intestinal, uterine, and skin ~//8 T  cells ex- 
press  the V~/7, V~/6, and V~/5 genes, respectively, whereas 
systemic ~/~ T  cells predominantly express the V'y4 gene 
(9, 10). 
Studies of TCP,.-deficient mice suggest an important role 
for ~//~  T  cells in immune responses to intracellular bacte- 
ria and parasites  (11-13). The ~//~  T  cells appear to be re- 
quired for control ofmycobacterial infection (I 1) and con- 
tribute  to  immunity  after  Plasmodium  yoelii  vaccination, 
since ~//~ TCR-deficient (TCR_~ -/-) mice do not respond 
normally to these intracellular microorganisms (12). The ~//~ 
T  cells also play an accessory role in the late stages of pro- 
tective  immune  responses  to  Mycobacterium  bovis  Bacillus 
Calmette-Guerin (13). These observations clearly implicate 
~//~ T cells in microbial immunity, but the precise function 
of ~//8 T  cells  in specific immune responses remains  un- 
clear. Our previous studies suggested that ~//~  T  cells  are 
important for the maintenance of mucosal IgA responses in 
the presence of systemac unresponsiveness or tolerance in- 
duced by oral immunization (14, 15). 
To examine the role of ~//g T  cells in the induction and 
regulation  of mucosal  immunity,  we  compared  the  im- 
mune responses in TCt(8 -/- and control mice to oral im- 
munization  with  tetanus  toxoid  (TT)  and  cholera  toxin 
(CT) as mucosal adjuvants. Tins immunization regimen in- 
duces intestinal secretory IgA  (S-IgA)  responses as well as 
circulating lgG and lgA antibodies to both antigens in nor- 
mal mice (16, 17), thus allowing examination of the role of 
~//~ T  cells in both mucosal and systemic responses. In this 
communication, we report that in contrast to their normal 
counterparts, TCtI.B  -/- mice display significant alterations 
in IgA responses induced by oral immunization. 
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ducing cells ofIgM (E]), IgG (I7'1), and lg,  A (11) 1so- 
types were exalruned  in  gut-assocmted  tissues and 
the spleen by an ELISPOT assay (/3) Irmnunofluo- 
rescence  staining  of small mtesnne  tissue sections 
from TCR8  -  and control TCR8 +'* mace. IgA- 
containing  cells were visualized by mcubanon wath 
bIonnylated goat anti-mouse ot F(ab')2 followed by 
avldm-AMCA. Results represent  the values (mean 
•  SEM) for 12 mace m each expenmental group. 
Materials  and Methods 
y/t3 T  Cell-deficientMice.  The  TCR~--  mice  were  con- 
structed by introducing germline mutations  in the TCR-b chain 
gene on a (129/Ola  ￿  C57B1/6)  (H-2  b) background  (18).  The 8 
chain-deficient  and  (129/O1a  ￿  C57B1/6)F2  normal  mace 
(TCR~*' +) were barrier maintained in Trexler isolators and have 
remained  pathogen  antibody  negative.  At  5-6  wk  of age,  the 
mice were removed from the colony isolator umt, housed in rni- 
croisolator  cages  m  horizontal  laminar  flow  cabinets,  and  pro- 
vlded stenle food and water ad hb. The mice were between 7 and 
10 wk of age at the beginmng of the expenment. 
Immunization.  Mice were immunized orally on days 0, 7, and 
14 with 0.25  ml PBS containing a nfixture of vaccine-grade TT 
(250 Dg/mouse; kindly provided by Dr.  Patricia J. Freda Pmtro- 
bon  [Connaught  Laboratories  lnc,  Swiftwater,  PA])  and  CT 
(10 I.Lg/mouse;  List  Biologic Laboratories,  Inc.,  Campbell,  CA) 
(16,  17). 
Antibody Assays.  Antibody  tlters  in  serum  and  fecal extracts 
were  determined  by  ELISA  (16,  17).  Assay  plates  (Falcon  MI- 
crotest; Becton Dickinson & Co., Oxnard, CA) were coated with 
an optimal concentration of TT (100  p.l of 5  p,g/ml TT, equiva- 
lent to 0.8 floculatlon units/ml) or recombinant CT-B 000 ~1 of 
5  ptg/rrd of CT-B; List Biological Laboratories Inc.) m  PBS.  End 
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density at  414 nm (OD414)  of >0.1  U  above negative control 
values after a 15-rain incubation. In some experiments,  the plates 
were coated with  goat anti-mouse  Ig (Southern Biotechnology 
Associates,  Birmingham,  AL) at  2  p-g/ml  (100  p-l/well).  Total 
lgM, lgG, and lgA levels in serum saliva, bile,  and fecal extracts 
were estimated by comparison with serial dilutions  of mouse IgM, 
lgG, and IgA standards (Southern Biotechnology Associates). 
Enumeration ofAntibody-producingCells.  The  spleen  was  re- 
moved aseptically,  and single-cell  suspensions  were prepared  as 
described (14, 15). Peyer's patches  carefully excised from the in- 
testinal  wall were dissociated  using the neutral protease enzyme 
Dispase |  (Boehringer Mannheim Corp., Indianapolis,  IN) inJok- 
lik-modified  medium  (Life Technologies,  Inc.,  Gaithersburg, 
MD)  to  obtain  single-cell  preparations  (16,  17). Mononuclear 
cells in the lamina propria were isolated after removal of PP from 
the small intestine  using a combination of enzymatic dissociation 
and  discontinuous  Percoll  gradients  (Pharmacia,  Uppsala,  Swe- 
den)  (6,  19). Mononuclear cells in the interface  between the 40 
and  75%  layers  were  removed,  washed,  and  resuspended  in 
RPMI  1640  containing  10% FCS.  An enzyme-linked immuno 
spot assay was used to detect cells producing IgM, IgG, and IgA 
antibodies  (14,  16). 96-well nitrocellulose  plates  (Millititer  HA; 
Millipore  Corp.,  Bedford,  MA)  were  coated  with  goat  anti- 
mouse Ig at 2 Ixg/ml (100 Ixl/well) to detect total IgM, IgG, and 
IgA antibody-forming cells (AFC),  5 Izg/ml of CT-B  (100  IXl/ 
well)  for anti-CT-B--specific AFCs, or 5 Ixg/n-d of TT (100 bd/ 
well) for anti-TT-specific AFC (16, 19). 
Immunohistology of the Small Intestine.  Samples  of mouse jejunum 
and ileum were obtained from TCR8 -/-  and control mice for 
conventional histology and staining  of antibody-containing cells 
(19).  1-cm  portions  of intestine  were  opened  longitudinally, 
mounted on thin cards,  and washed in three changes of PBS at 
4~  over a period of 2 h to remove tissue-associated  lg. The tis- 
sue was then  fixed in  5% glacial  acetic  acid in 95%  ethanol  at 
-20~  for 24 h before paraffin embedding. 4-p-m-thick serial tis- 
sue sections were mounted on glass slides, and lg-containing cells 
were visualized  by three-color staining  with  FITC-labeled goat 
(Fab')2  anti-mouse  Ix  (Southern  Biotechnology  Associates), 
RITC-labeled goat F(ab')2 anti-mouse "/ (Southern Biotechnol- 
ogy Associates), and biotinylated F(ab')2 anti-mouse ot (Southern 
Biotechnology Associates) followed by avidin-7-amino-4-methylo- 
coumarin-3-acetic acid (AMCA; Jackson ImmunoResearch Lab- 
oratories,  Inc., West Grove, PA [19]). 
Statistics,  Mean numbers of AFC in the different  tissues were 
compared among experimental and control groups by Wilcoxon 
signed-rank test. Mean percentages of Ig-containing cells per villi 
were  calculated  from  multiple  determinations  of experimental 
and control groups and compared by Wilcoxon signed-rank test. 
Results 
Deflciency of lgA-producing Cells in TCR 8 -/- Mice.  The  vast 
majority of ~//8 T  cells are located in the epithelium of the 
small  intestine  of normal  mice  (1-3),  suggesting that  ab- 
sence of this T  cell subset in this mucosal effector site could 
influence immunological homeostasis. Since previous stud- 
ies have  not assessed ",//B T  cells for their participation  in 
regulation of humoral and mucosal immune responses, we 
initially examined the effects ofTCR-8  gene disruption on 
the  numbers  of IgM-,  IgG-,  and  IgA-producing cells  in 
systemic and mucosal tissues,  and levels of IgM, IgG, and 
IgA present in serum, saliva, bile, and fecal extracts. When 
the frequency of Ig-producing cells was compared between 
spleens  of  nonimmunized  TCRB -/-  mice  and  control 
mice of the  same  (129  X  B6)F  2 background  (TCRB+/+), 
comparable numbers of IgM- or IgG-producing cells were 
seen. In constrast, the numbers of IgA-secreting cells in the 
intestinal  lamina propria and Peyer's patches of TCR8 -/- 
mice  were  significantly lower  than  in  control  TCR8 +/+ 
mice (P <0.02, Fig. 1 A). 
The frequency of IgA-containing cells was also evaluated 
in tissue  sections  of jejunum  and ileum by immunohisto- 
logical analysis. Enumeration of the IgA-producing cells in 
the lamina propria of the small intestine indicated a reduc- 
tion of IgA plasma cells in TCR8 -/-  mice.  The numbers 
of intestinal  IgA plasma  cells  in  normal  and  mutant  mice 
were  460  +  63  and  116  +-  22/10  fields,  respectively  (P 
<0.002, Fig. 1 B). The reduction in IgA-producing cells in 
TCR8 -/-  mice was  confirmed by an  assessment  of anti- 
body levels in serum, saliva,  bile, and fecal extracts using an 
isotype-specific  ELISA.  The  IgA levels  were  reduced  by 
N80%  in  fecal  extracts  obtained  from  TCR8 -/-  mice 
compared with fecal IgA levels in control TCR8 +/+  mice 
(P <0.001,  Table  1).  Serum IgA levels were also reduced 
in TCRB -/-  mice (P <0.003), whereas IgM and IgG lev- 
els were normal (Fig. 2, Table 1).  Further,  IgA levels in sa- 
liva  and  bile  of TCRB -/-  mice  were  significantly lower 
than controls (P <0.005, Table  I). 
Reduction of TT-specific  IgA Responses  in Orally Immunized 
TCR8 -/-  Mice.  The antibody response to TT was exam- 
ined in TCRB -/- mice that were immunized orally with a 
vaccine  containing TT  and  CT  to  examine  the  potential 
involvement  of ~//8  T  cells  in  antigen-specific  IgA  re- 
sponses. When TT-specific serum antibody responses were 
compared after  three  oral  doses  of the  combined vaccine, 
the TCR8 -/- mice and their normal littermates (TCR8 +/+) 
produced almost identical levels of IgG antibodies  to both 
proteins, whereas lower serum IgA responses were seen in 
TCRB -/-  mice  (P <0.003,  Table  2).  When TT-specific 
antibodies  were  assessed  in  fecal  samples,  lower  IgA re- 
sponses were noted in the TCR8 -/-  mice (P <0.005, Ta- 
ble 2). To evaluate these findings at a cellular level, we ex- 
amined the frequency of antigen-specific AFC in different 
tissues  of mice immunized orally with the  combined vac- 
cine by using the ELISPOT assay. A reduction in the num- 
bers  of TT-specific  IgA AFC  was  noted  in both  Peyer's 
patches and intestinal lamina propria in the TCR8 -/- mice 
when compared with control mice (P <0.01, Fig. 3 A). 
Characterization  of Antibody  Response  to  Cholera  Toxin  B 
Subunit in TCR8 -/- Mice.  It is possible that hyporespon- 
siveness  of TCRB -/-  mice  to  combined  TT  was  due  to 
unresponsiveness  to  the  adjuvant  effect  of CT.  Since  the 
CT molecule possesses strong immunogenicity in addition 
to mucosal adjuvant activity for IgA responses, we could also 
measure IgA responses to the CT antigen.  Serum and fecal 
extracts as well as mononuclear cells from various tissues of 
both TCR8 -/-  mice and controls were obtained  1 wk af- 
ter the last oral dose of the combined vaccine for analysis of 
CT-B--specific responses  by ELISA and ELISPOT assays. 
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in TCR3 -/- Mice 
Mouse strains  Fecal  Saliva  Bile  Serum 
la.glml  nglml  p.glml  p.glml 
TCR.8 -/-  2 +  1  244 +  19  270 +  30  25 -+ 3 
TCIK8 +/+  11  -+ 2  753 -+ 100  849 +  155  125 -+ 10 
Values represent the mean endpoint titer + SEM for nine mice in each 
experimental group. 
When CT-B---specific serum responses were compared be- 
tween  TCR~ -/-  and normal mice, lower CT-B-specific 
IgA titers were detected in the former (P <0.008, Table 2). 
When CT-B--specific antibody titers were examined in fe- 
cal  extracts,  a  significant  decrease  in  the  antigen-specific 
IgA levels was observed in TCR8 -/- mice (P <0.01,  Ta- 
ble  2).  Reductions  in  CT-B-specific IgA-producing cells 
in both intestinal lamina propria and Peyer's patches were 
also observed in orally immunized TCR8 -/- mice (P <0.03, 
Fig. 3 B). 
Discussion 
These  studies  suggest  that  ~//8  T  cells  exert  an  unex- 
pected role in mucosal immunity. Decreased levels of total 
serum and secretory IgA as well as the reduction of IgA re- 
sponses to both tetanus toxoid and cholera toxin antigens 
in TCR8 -/- mice suggests that ~//8 T  cells can regulate the 
IgA response. In contrast, we found that IgM and IgG anti- 
body responses were unimpaired in TCR~ -/- mice when 
compared with normal controls. 
CD4 + o#[3 T  cells  have been shown to be essential for 
IgA B cell responses (for review see reference 20), whereas 
the results of this study suggest that ~//8  T  cells  also  may 
regulate the mucosal IgA immune response. The helper T 
cells  that  preferentially  produce  IL-4,  IL-5,  IL-6,  and 
IL-10,  the  Th2  subset  of CD4 +  cells,  promote  IgA  re- 
sponses (16,  21-23).  Our earlier studies indicated that oral 
immunization of normal mice with the combined TT and 
CT vaccine induced Th2-type cells in the IgA mucosal re- 
sponse (16),  and TCR-[3 -/- mice are essentially devoid of 
mucosal IgA-producing cells (Fujihashi, K., M.-N. Kweon, 
M. Marinaro, K. Imaoka, R.J. Jackson, J.R. McGhee, and 
H. Kiyono, manuscript in preparation).  Function-loss mu- 
tations in the  CD40L gene in humans  and mice result in 
the  failure  to  generate  T  cell-dependent  secondary  hu- 
moral immune responses, including antibodies of IgG and 
IgA isotype (24, 25). A severe impairment of IgA responses 
is  also  observed in  anti-CD4-treated  and  athyInic  mice, 
which also have reduced germinal center development and 
few  IgA-producing  cells  in  the  intestinal  lamina  propria 
(19,  26).  The interaction between CD4 + Th2 cells  and B 
cells  that  are  induced  to  undergo  isotype  switching  nor- 
really occurs in germinal centers  (20),  where  the  interac- 
tion between CD40L on the activated CD4 + 0~/[3 T  cells 
and  the  CD40  molecule  on B  cells  also  initiates  a  signal 
needed for the isotype switch process (for review see refer- 
ence 27). A special subset of the CD4 + ct/[3 T  cells is thus 
essential for the induction of systemic IgA responses. 
Our present results suggest that y/8 T  cells may serve an 
important regulatory role for mucosal IgA responses in that 
TCR8 -/- mice possess normal numbers of functional or/J3 
T cells but display markedly decreased IgA responses to oral 
immunization. The previous studies also suggested that ~//8 
T  cells  may play an important role in the maintenance  of 
mucosal IgA responses in the presence of oral tolerance (14, 
15). One possible explanation for this unexpected finding is 
that ~//8 T  cells positively influence ~x/[3 Th2 cells that reg- 
ulate IgA immune responses in mucosal tissues.  In this sce- 
nario, a triad interaction between mucosal ~//8 T  cells, o~/[3 
Th2-type cells, and IgA B cell precursors is involved in the 
induction  of maximal IgA responses to  oral antigens.  Ex- 
periments in mice (11,  13, 28) and in chickens (29,  30) in- 
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Figure  2.  IgM,  IgG, and IgA 
levels in serum and fecal extracts 
of  TCR8 -/-  and  TCtk8  +/+ 
mice. These levels were deter- 
mined by an ELISA using mouse 
IgM,  IgG, and  IgA  standards. 
Values are mean -- SEM for nine 
mice  in  each  experimental 
group. 
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Immunization with TT and CT Antigens  in TCR~  -/- Mice 
Antibody titer (Log2) 
Fecal  Serum 
Mousc 
Antigen  strains  IgA  IgA  IgG  IgM 
TT 
CT-B 
TCtLB  -/- 5.0 +  0.3  8.0 +  0.3  16.6 +  0.3  11.6 +- 0.3 
TCR8 +/+ 7.5  -+ 0.5 10.8 -+ 0.4 16.8 +  0.7 11.4 +  0.4 
TCR8 -/- 5.7  +  0.5 10.6 ~  0.4 16.2 +- 0.2 11.0  +  0.2 
TCR8 +/+ 8.3 -+ 0.3  12.5 -+ 0.3  17.0 --- 0.5  10.7  +-- 0.4 
Values represent the mean end point titer + SEM for nine mice in each 
experimental group. The antibody end point titration was performed 
by ELISA as described in Materials and Methods. 
deed  suggest  that  bidirectional  interactions  between  o~/~ 
and  ~//8  T  cells  may  have  functionally important  conse- 
quences. Alternatively, the ~//8 T  cells could have a direct 
effect either on the differentiation ofslgA  + B cells or in the 
induction  of the  mucosal  IgA  switch  process.  A  recent 
study  indicates  that  activated  ~//B  T  cells  can  express 
CD40L and thereby induce an IgE B  cell response  (31).  It 
thus seems possible that mucosal CD40L  §  ~//B  T  cells are 
capable of direct interaction with CD40 + B  cells to induce 
IgA responses.  The observation of significant IgA produc- 
tion  in  CD40  -/-  and  CD40L  -/-  mice  (25,  32,  33)  also 
raises the possibility of an ahernative set of interaction mol- 
ecules that could allow ~//8 (or o~/[3) T  cells in the mucosal 
compartment to induce IgA responses to ingested antigens. 
Our previous studies and those of others indicate that ~//8 
IEL can produce an array of Thl- and Th2-type cytokines, 
as well as TNF-~ and TGF-13 (34, 35). Specifically, the "y/B 
IELs can secrete IL-5 and IL-6, which are key cytokines for 
inducing slgA  § B cells to differentiate into IgA plasma cells 
(34,  35).  Moreover, ~//B  T  cells in other mucosal effector 
tissues,  such as  the  salivary glands,  are  committed to pro- 
duce IL-5 and IL-6 (36), and the frequency oflgA-produc- 
ing cells is reduced in the salivary glands of TCRB -/- mice 
(data not shown).  IgA-producing cells  are  also  greatly re- 
duced in intestinal  tissues  of IL-6  -/-  mice  (37).  The im- 
paired IgA responses in TCILB  -/- mice could therefore re- 
flect the absence ofmucosal ~//8 T  cells that produce IL-5 
and IL-6. 
Yet another possible explanation for our findings is that 
the lack of ~//B  T  cells in intestinal  epithelium  negatively 
influences  epithelial  cell production  of TGF-[3  and  IL-6, 
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Figure 3.  Comparison of (A) TT- and (B) CT-B-specific antibody responses in TCRB -/- and control mice immunized orally with a combined vac- 
cine containing TT and CT. Mononuclear cells isolated fi~om spleen, Peyer's patch, and lamina propria of both TCILB -/- and control mice were sub- 
jected to the TT- and CT-B-specific ELISPOT assay. Antigen-specific IgM (1--1), IgG ([~) and IgA (l) AFC were enumerated. Results represent the val- 
ues (mean •  SEM) for rune mice in each experimental group. 
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factors, respectively (38,  39).  T  cell-derived cytokines, in- 
cluding IFN-'y, TNF-ot, and IL-4, can influence epithelial 
cell functions  (40,  41).  All of these  cytokines can be pro- 
duced by ~//8 IEL (34, 35), and ~//8 T  cells may influence 
epithelial  cell  growth  and  function.  In fact,  reduction  in 
both the numbers of intestinal epithelial cells and their level 
of MHC  class II expression have been observed in TCR-8 
gene-disrupted  mice  (42).  Further,  intraepithelial  T/8  T 
cells  have  been  shown  to  modulate  growth  of epithelial 
cells  via the production of keratinocyte growth factor (43). 
The  absence  of ~//8  T  cells  in  the  intestinal  epithelium 
could therefore  compromise TGF-[3 and IL-6 production 
by epithelial cells,  which, in turn, may result in diminished 
IgA responses. 
In conclusion, T/8 T  cells may influence  IgA B  cell re- 
sponses  to  ingested  antigens  via  their  interactions  with 
other T  cells  and mucosal epithelial  cells.  Mucosal "//8  T 
cells may thus regulate production of key cytokines for IgA 
B cell development by CD4 + a/J3 T  cells (e.g., IL-5, IL-6, 
and IL-10) and epithelial cells (e.g., TGF-[3 and IL-6). The 
interactions between ~//8 T  cells,  c~/[3 T  cells,  and epithe- 
lial  cells  in  the  induction  and  regulation  of mucosal  im- 
mune  responses  could thus  represent  a  fertile  field  for fu- 
ture investigation. 
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